Symptom-cluster pattern most consistent with mitochondrial dysfunction, with secondary neuroinflammation signals. Recovery stage: intake only. This is a pattern for clinical review — not a diagnosis.
| Marker | Result | Band |
|---|---|---|
| Citrinin (DHC) | 30.85 | high |
| Ochratoxin A (OTA) | 11.33 | high |
| Homocysteine | 24.2 | high |
| MCH | 33.1 | high |
| B. burgdorferi C6 peptide IgG | 14.1 | high |
| B. burgdorferi VlsE1 IgG | 13.5 | high |
| Streptococcal A IgG | 16.5 | high |
| Herpes simplex virus 1 (HSV-1) IgG | 13.1 | high |
| Mycoplasma pneumoniae IgG | 13.8 | high |
| Parvovirus B19 VLP VP1/Vp2 Co Capsid IgG | 29.1 | high |
| B. burgdorferi p34 (OspB) IgG | 10.5 | high |
| B. burgdorferi p39 (BmpA) IgG | 10.5 | high |
No high or critical safety flags. No safety review recorded.
Clinical decision-support only — not a diagnosis. Axiom recognizes symptom-cluster patterns and organizes evidence. Scores are heuristic and attributable. They do not diagnose, interpret labs in isolation, or recommend or dose treatment. All clinical decisions rest with the reviewing physician.